AI Terminal
Essity
Legal Proceedings Report • Jan 8, 2026
2912_iss_2026-01-08_5febb5b1-9c55-4c31-8b21-d06a1928b011.pdf
Legal Proceedings Report
Open in ViewerOpens in native device viewer
Press release
Stockholm, January 8, 2026
Discontinued lawsuit against Essity regarding bond loans
The funds that have brought an action against Essity in the English courts regarding bond loans issued by the company have chosen to discontinue their action. The case is therefore closed.
On October 17, 2024, Essity announced that the company had received a request for early redemption from certain investors regarding bonds maturing in 2029, 2030 and 2031, respectively. In December 2024, the funds initiated proceedings against Essity in the English courts. The parties have entered into an agreement with conditions, among other things, that they have no claims against each other due to Essity's sale of its shares in Vinda. The funds subsequently discontinued their action before the court. Essity has not changed its view that the action was unfounded and has not paid the funds or otherwise compensated them in the dispute.
NB: This information is such that Essity Aktiebolag (publ) is obligated to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out below, at 13:45 CET on January 8, 2026.
Karl Stoltz, Public Relations Director, +46 709 426 338, [email protected]
Contact information
Per Lorentz, Vice President Corporate Communications, Tel: 073 313 30 55, [email protected] Sandra Åberg, Vice President Investor Relations, Tel: 070 564 96 89, [email protected]
About Essity
Essity is a global, leading hygiene and health company. Every day, our products, solutions and services are used by a billion people around the world. Our purpose is to break barriers to well-being for the benefit of consumers, patients, caregivers, customers and society. Sales are conducted in approximately 150 countries under the leading global brands TENA and Tork, and other strong brands such as Actimove, Cutimed, JOBST, Knix, Leukoplast, Libero, Libresse, Lotus, Modibodi, Nosotras, Saba, Tempo, TOM Organic and Zewa. In 2024, Essity had net sales of approximately SEK 146bn (EUR 13bn) and employed 36,000 people. The company's headquarters is located in Stockholm, Sweden and Essity is listed on Nasdaq Stockholm. More information at essity.com.
